Fundz

Lakewood-Amedex Biotherapeutics Inc. closed a $7.5 million Series C financing in April 2026, but still needs more capital for operations due to a net loss of $0.9 million.

PRIVATEMay 22, 2026

Amount Raised

$7.5 Million

Round Type

Series C

University ParkBiotechnologyHealthcarePharmaceutical

Description

Lakewood-Amedex Biotherapeutics Inc. reported a net loss of $0.9 million in Q1 2026 as operating expenses rose. They closed a $7.5 million Series C financing in April to improve liquidity. However, there remains substantial doubt about long-term viability without further funding

Quick answer

Lakewood-Amedex, Inc. raised $7.5 Million in a Series C round, dated May 22, 2026. Lakewood-Amedex, Inc. is based in University Park, Florida, United States.

How much did Lakewood-Amedex, Inc. raise?
Lakewood-Amedex, Inc. raised $7.5 Million in a Series C round on May 22, 2026.
What does Lakewood-Amedex, Inc. do?
Lakewood-Amedex is a privately held pharmaceutical company that has discovered a novel class of antimicrobial agents called Bisphosphocins™.
Where is Lakewood-Amedex, Inc. based and how big is it?
Lakewood-Amedex, Inc. is based in University Park, Florida, United States. Fundz records about 10 employees.
Who are the decision-makers at Lakewood-Amedex, Inc?
Fundz holds 1 contact at Lakewood-Amedex, Inc., including the Chief Medical Officer, SVP | Global Healthcare Executive | Clinical Strategy and Trial Execution | Regulatory Filings | Medical Brand Positioning. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical around the same time

Companies in the same sectors as Lakewood-Amedex, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $1.6M on June 30, 2026.
  • Ascendia Pharmaceuticals raised $4.1M on June 26, 2026.
  • AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
  • CurifyLabs raised $14M (Series A) on July 6, 2026.
  • CalciMedica raised $1.2M (Series A) on July 3, 2026.
  • NewcelX raised $2.9M on July 3, 2026.

Who to call at Lakewood-Amedex, Inc., and when

A new round usually means Lakewood-Amedex, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lakewood-Amedex, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lakewood-Amedex, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lakewood-Amedex, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lakewood-Amedex, Inc.

Location

3030 UNIVERSITY PARKWAY

University Park, Florida, United States

About

Lakewood-Amedex is a privately held pharmaceutical company that has discovered a novel class of antimicrobial agents called Bisphosphocins™.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lakewood-Amedex, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsThomas B., Chief Medical Officer, SVP | Global Hea…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Lakewood-Amedex, Inc.'s next move

See what Strategic adds

Lakewood-Amedex, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.